Economic Impact of Switching From Metoprolol to Nebivolol for Hypertension Treatment

Status unconfirmed

Conditions studied: Hypertension

In brief

This is a retrospective data analysis of patients with high blood pressure (hypertension) who took metoprolol for a minimum of 6 months who then switched to taking nebivolol for a minimum of 6 month to treat hypertension. These patients will be identified from a large medical claims database. This study tests the hypothesis (alternative, higher or lower) that average patient monthly health care administrative cost changes after switching from metoprolol to nebivolol.

Key facts

Study ID

NCT01758263

Run by

Forest Laboratories

People needed

3000

Starts

2012-10-01

Expected to finish

2013-07-01

Last updated by the study team

2013-01-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Be at least 18 years old at initiation of metoprolol (or first date on metoprolol treatment between 2007 and 2011)
• Had one or more inpatient or outpatient claims with a primary or non-primary diagnosis of hypertension (ICD-9-CM 401.xx-405.xx)
• Received nebivolol treatment continuously (defined as supply gap <30 days) for at least 6 months after initiation
• Received metoprolol treatment continuously for at least 6 months prior to switching to (initiation of) nebivolol (defined as metoprolol was discontinued whereas a prescription for nebivolol was filled)
• Had at least 12 months of continuous enrollment (as verified using enrollment file): 6 month prior to nebivolol initiation and 6 months following nebivolol initiation.

Where it is running

• Forest Investigative Site 0 — Jersey City, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.